-
Sciences. The Marcucci laboratory studies the pathogenesis of acute myeloid leukemia (AML) and development of new treatments for AML based on these discoveries. We seek an independent and highly motivated
-
. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and
-
(EVs), for groundbreaking minimally invasive diagnostics. Uncover disease-specific molecules within EVs using cell biology and super-resolution microscopy. Contribute to developing a revolutionary
-
medicine, vascular biology, bioengineering, and data science, Dr. Chen leads an active research program focused on noncoding RNAs and endothelial stress response. Her team integrates innovative high
-
motivated and talented individual to fill a postdoctoral position in the field of gamma-herpesvirus structural biology. The goal of the postdoctoral candidate will be to elucidate the mechanisms of gamma
-
). We are one of the few interventional oncology groups in the United States with a basic science lab, large animal tumor model, and several active clinical trials, which enables us to translate new
-
11:148(1):dev196048; Development 2021 Oct 1:148(19):dev199738; Nat Commun 2022 Jul 28:13:4364; Nat Commun 2022 Nov 2:13:6552). · PhD or M.D/PhD degree in Cancer Biology, Molecular Biology
-
synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and their
-
(EVs), for groundbreaking minimally invasive diagnostics. Uncover disease-specific molecules within EVs using cell biology and super-resolution microscopy. Contribute to developing a revolutionary
-
of the following areas within the laboratories of Dr. Ling Li, Professor in the Department of Hematological Malignancies Translational Science, Department of Pediatrics, and Gehr Family Center for Leukemia Research